| Date | Time | Source | Headline | Symbol | Company |
| 06/07/2024 | 2:15PM | iHub Newswire | FeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio | | |
| 09/22/2011 | 1:00PM | Zacks | Pharmaceuticals Stock Outlook - Sept. 2011 - Industry Outlook | NASDAQ:GILD | Gilead Sciences Inc |
| 09/20/2011 | 6:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 09/20/2011 | 11:00AM | Zacks | Gilead's 2nd Quad Trial Meets Goal - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 09/19/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at the UBS Global Life Sciences Conference on Tuesday, September 20 | NASDAQ:GILD | Gilead Sciences Inc |
| 09/19/2011 | 4:05PM | Business Wire | Gilead’s Second Pivotal Phase 3 Clinical Study of the Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Obj... | NASDAQ:GILD | Gilead Sciences Inc |
| 09/13/2011 | 10:29PM | Dow Jones News | Q&A: Living Large With Stocks Under $10 ---- By Johanna Bennett | NASDAQ:GILD | Gilead Sciences Inc |
| 09/07/2011 | 11:53AM | Zacks | Gilead Amends HCV Combo Study - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 09/06/2011 | 9:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 09/06/2011 | 7:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 09/04/2011 | 11:00AM | Business Wire | Gilead Amends Study Design for Ongoing Hepatitis C Clinical Trials That Include GS 9190, Pegylated Interferon & Ribavirin, & ... | NASDAQ:GILD | Gilead Sciences Inc |
| 08/31/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at Baird’s 2011 Health Care Conference on Thursday, September 8 | NASDAQ:GILD | Gilead Sciences Inc |
| 08/26/2011 | 9:00AM | Marketwired | Opportunity Within Market Turmoil - Research Report on United Therapeutics Corporation and Gilead Sciences, Inc. | NASDAQ:GILD | Gilead Sciences Inc |
| 08/25/2011 | 9:45AM | Zacks | UTHR's Oral Remodulin Misses Goal - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 08/25/2011 | 9:31AM | PR Newswire (US) | Critical Alerts for Microsoft, CF Industries, Gilead Sciences, BB&T, and China Mobile Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 08/22/2011 | 2:18PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 08/18/2011 | 9:00AM | Marketwired | Insight Into Market Ahead - Equity Research on Gilead Sciences, Inc. and Bristol Myers Squibb Co. | NASDAQ:GILD | Gilead Sciences Inc |
| 08/16/2011 | 11:00AM | Zacks | Gilead's Quad Meets Study Goal - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 08/15/2011 | 8:30AM | Business Wire | Gilead’s Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102 | NASDAQ:GILD | Gilead Sciences Inc |
| 08/11/2011 | 11:00AM | Zacks | Another GILD Combo HIV Drug Cleared - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 08/11/2011 | 7:16AM | Dow Jones News | US Stock Futures: HOT STOCKS TO WATCH | NASDAQ:GILD | Gilead Sciences Inc |
| 08/10/2011 | 5:59PM | Dow Jones News | Gilead: FDA Approves Single-Pill Drug For HIV Patients New To Therapy | NASDAQ:GILD | Gilead Sciences Inc |
| 08/10/2011 | 5:01PM | Business Wire | Gilead Sciences Resolves U.S. Food and Drug Administration Warning Letter Related to San Dimas Manufacturing Facility | NASDAQ:GILD | Gilead Sciences Inc |
| 08/10/2011 | 4:17PM | Business Wire | U.S. Food & Drug Administration Approves Gilead Sciences’ Complera™, a New Complete Once-Daily, Single-Tablet Regimen for... | NASDAQ:GILD | Gilead Sciences Inc |
| 08/10/2011 | 4:05PM | Business Wire | U.S. Food & Drug Administration Approves Gilead Sciences’ Complera™, a New Complete Once-Daily, Single-Tablet Regimen for... | NASDAQ:GILD | Gilead Sciences Inc |
| 08/08/2011 | 4:15PM | Business Wire | Gilead Sciences to Purchase Biologics Process Research and Clinical Manufacturing Facility from Genentech | NASDAQ:GILD | Gilead Sciences Inc |
| 08/05/2011 | 4:49PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/28/2011 | 9:00AM | PR Newswire (US) | IU Confidential Publishes Biotech Investment Report | NASDAQ:GILD | Gilead Sciences Inc |
| 07/27/2011 | 10:45AM | Zacks | HIV Franchise Drives Gilead - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2011 | 8:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |